BioRegenx, Inc.
BRGX
$0.008
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4,559.56% | 88.89% | -404.23% | -174.56% | 89.81% |
| Total Depreciation and Amortization | 0.00% | -33.98% | 334.88% | 16,575.00% | 0.00% |
| Total Amortization of Deferred Charges | 66.28% | -65.32% | -- | -- | -- |
| Total Other Non-Cash Items | 6,879.58% | -111.83% | 566.84% | 25.36% | -88.23% |
| Change in Net Operating Assets | 239.66% | -70.28% | -34.64% | 183.50% | -6,080.49% |
| Cash from Operations | 63.46% | 90.21% | -961.08% | 115.07% | 13.37% |
| Capital Expenditure | -- | -100.00% | 167.81% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 199.99% | -9,151.76% | -- |
| Cash from Investing | -- | -100.00% | 199.00% | -9,446.84% | -- |
| Total Debt Issued | -97.36% | 127.64% | -132.24% | 24,419.23% | -96.35% |
| Total Debt Repaid | 17.48% | -116.61% | 167.76% | -457.93% | 10.38% |
| Issuance of Common Stock | -- | -- | -- | -- | 734.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -200.00% | -- | -- |
| Cash from Financing | -114.87% | 100.25% | -197.88% | 3,598.31% | 342.20% |
| Foreign Exchange rate Adjustments | 253.85% | -620.00% | -50.00% | 211.11% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -192.13% | 122.36% | -407.14% | -116.62% | 140.26% |